A Blood Hepatocellular Carcinoma Signature Recognizes Very Small Tumor Nodules with Metastatic Traits
Open Access
- 20 May 2024
- journal article
- research article
- Published by Xia & He Publishing in Journal of Clinical and Translational Hepatology
- Vol. 12 (6) , 551-561
Abstract
Hepatocellular carcinoma (HCC) cases with small nodules are commonly treated with radiofrequency ablation (RFA), but the recurrence rate remains high. This study aimed to establish a blood signature for identifying HCC with metastatic traits pre-RFA.Keywords
This publication has 39 references indexed in Scilit:
- Ultrasensitive and affordable assay for early detection of primary liver cancer using plasma cell‐free DNA fragmentomicsHepatology, 2021
- Genomic Analysis of Vascular Invasion in HCC Reveals Molecular Drivers and Predictive BiomarkersHepatology, 2021
- Liver stiffness measured by MR elastography is a predictor of early HCC recurrence after treatmentEuropean Radiology, 2020
- Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional AnalysisJournal of Gastrointestinal Surgery, 2020
- Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver DiseasesHepatology, 2018
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 updateHepatology International, 2017
- Natural history of large regenerative nodules and dysplastic nodules in liver cirrhosis: 28-year follow-up studyHepatology International, 2015
- Survival Rates Are Comparable After Radiofrequency Ablation or Surgery in Patients With Small Hepatocellular CarcinomasClinical Gastroenterology and Hepatology, 2011
- Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis #Hepatology, 2009
- Estimation of the Youden Index and its Associated Cutoff PointBiometrical Journal, 2005